Leila Chebane

462 total citations
26 papers, 285 citations indexed

About

Leila Chebane is a scholar working on Toxicology, Pharmacology and Epidemiology. According to data from OpenAlex, Leila Chebane has authored 26 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Toxicology, 7 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in Leila Chebane's work include Pharmacovigilance and Adverse Drug Reactions (12 papers), Drug-Induced Adverse Reactions (6 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Leila Chebane is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (12 papers), Drug-Induced Adverse Reactions (6 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Leila Chebane collaborates with scholars based in France, Canada and Spain. Leila Chebane's co-authors include Jean‐Louis Montastruc, François Montastruc, Vanessa Rousseau, Geneviève Durrieu, Haleh Bagheri, Emmanuelle Bondon‐Guitton, Justine Bénevent, Agnès Sommet, Maryse Lapeyre‐Mestre and Delphine Abadie and has published in prestigious journals such as Psychopharmacology, Journal of General Internal Medicine and Movement Disorders.

In The Last Decade

Leila Chebane

26 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leila Chebane France 11 67 51 42 42 38 26 285
Justine Bénevent France 11 45 0.7× 35 0.7× 40 1.0× 25 0.6× 92 2.4× 36 312
Yamato Kato Japan 13 136 2.0× 105 2.1× 48 1.1× 28 0.7× 44 1.2× 25 423
Francesco Giorgianni Italy 13 28 0.4× 51 1.0× 21 0.5× 46 1.1× 57 1.5× 24 451
Michele Tari Italy 13 37 0.6× 53 1.0× 59 1.4× 59 1.4× 78 2.1× 26 615
Giuseppe Cicala Italy 14 59 0.9× 43 0.8× 36 0.9× 26 0.6× 45 1.2× 32 405
Supriya Malhotra India 10 53 0.8× 45 0.9× 29 0.7× 139 3.3× 97 2.6× 65 469
Sigal Kaplan Israel 10 52 0.8× 21 0.4× 42 1.0× 37 0.9× 155 4.1× 48 389
Boyang Bian United States 9 20 0.3× 62 1.2× 31 0.7× 19 0.5× 32 0.8× 19 372
Tracey L. Mersfelder United States 12 26 0.4× 173 3.4× 32 0.8× 96 2.3× 64 1.7× 28 494
Bharti Chogtu India 12 19 0.3× 34 0.7× 18 0.4× 18 0.4× 26 0.7× 62 375

Countries citing papers authored by Leila Chebane

Since Specialization
Citations

This map shows the geographic impact of Leila Chebane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Chebane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Chebane more than expected).

Fields of papers citing papers by Leila Chebane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Chebane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Chebane. The network helps show where Leila Chebane may publish in the future.

Co-authorship network of co-authors of Leila Chebane

This figure shows the co-authorship network connecting the top 25 collaborators of Leila Chebane. A scholar is included among the top collaborators of Leila Chebane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Chebane. Leila Chebane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellière, Julie, Julien Mazières, Nicolás Meyer, Leila Chebane, & Fabien Despas. (2021). Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies. Diagnostics. 11(7). 1187–1187. 11 indexed citations
2.
Rousseau, Vanessa, et al.. (2020). Drug-Induced Hearing Loss in Children: An Analysis of Spontaneous Reports in the French PharmacoVigilance Database. Pediatric Drugs. 23(1). 87–93. 2 indexed citations
3.
Revet, Alexis, Laurent Chouchana, A.‐P. Jonville‐Béra, et al.. (2020). Adverse drug reactions in infants, children and adolescents exposed to antidepressants: a French pharmacovigilance study. European Journal of Clinical Pharmacology. 76(11). 1591–1599. 1 indexed citations
4.
Montastruc, François, et al.. (2020). Drug‐induced tics: An observational postmarketing study. Human Psychopharmacology Clinical and Experimental. 35(4). e2734–e2734. 3 indexed citations
5.
Rousseau, Vanessa, et al.. (2020). Fluoroquinolone-Induced Photosensitivity: A Chemical Fragment-Based Approach by a Case/Non-case Study in VigiBase®. Drug Safety. 43(6). 561–566. 9 indexed citations
6.
Rousseau, Vanessa, et al.. (2020). Can tramadol really induce hyponatraemia? A pharmacovigilance study. British Journal of Clinical Pharmacology. 87(2). 683–686. 5 indexed citations
7.
Sabatier, Pierre, Jacques Amar, François Montastruc, et al.. (2019). Breast cancer and spironolactone: an observational postmarketing study. European Journal of Clinical Pharmacology. 75(11). 1593–1598. 4 indexed citations
8.
Rousseau, Vanessa, Leila Chebane, Sophie Gautier, et al.. (2019). Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases. European Journal of Clinical Pharmacology. 75(12). 1705–1711. 7 indexed citations
9.
Montastruc, François, Justine Bénevent, Vanessa Rousseau, et al.. (2018). Fluoroquinolones and aortic aneurysms: Which fluoroquinolones are at risk?. Archives of Cardiovascular Diseases Supplements. 11(1). 152–153. 1 indexed citations
10.
Sommet, Agnès, Justine Bénevent, Vanessa Rousseau, et al.. (2018). What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®. Journal of General Internal Medicine. 34(4). 502–503. 19 indexed citations
11.
Rousseau, Vanessa, Leila Chebane, Amandine Gouverneur, et al.. (2018). Serious adverse drug reactions with sacubitril/valsartan Entresto®: a French pharmacovigilance survey. European Journal of Clinical Pharmacology. 74(7). 983–984. 6 indexed citations
12.
Durrieu, Geneviève, Vanessa Rousseau, Leila Chebane, et al.. (2017). Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database. Pediatric Drugs. 20(1). 81–87. 6 indexed citations
13.
Bénevent, Justine, Emmanuelle Bondon‐Guitton, Geneviève Durrieu, et al.. (2017). A comparative study of QT prolongation with serotonin reuptake inhibitors. Psychopharmacology. 234(20). 3075–3081. 32 indexed citations
14.
Montastruc, François, Haleh Bagheri, Isabelle Lacroix, et al.. (2017). Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting. Drug Safety. 41(5). 511–514. 28 indexed citations
15.
Montastruc, François, et al.. (2016). Ergot and non-ergot dopamine agonists and heart failure in patients with Parkinson’s disease. European Journal of Clinical Pharmacology. 73(1). 99–103. 8 indexed citations
16.
Rousseau, Vanessa, Robert Bourrel, Maryse Lapeyre‐Mestre, et al.. (2016). Drug–drug interactions with imatinib. Medicine. 95(40). e5076–e5076. 16 indexed citations
17.
Montastruc, Jean‐Louis, Leila Chebane, Vanessa Rousseau, et al.. (2016). Neurological and digestive bleeding with Direct Oral Anticoagulants versus Vitamin K Antagonists: The differences do not stop there! A pharmacovigilance study. Pharmacological Research. 118. 119–120. 3 indexed citations
18.
Chebane, Leila, Hadi Bagheri, Dominique Hillaire‐Buys, et al.. (2015). [Drug-induced pancreatitis. A review of French spontaneous reports].. HAL (Le Centre pour la Communication Scientifique Directe). 2 indexed citations
19.
Chebane, Leila, Haleh Bagheri, Dominique Hillaire‐Buys, et al.. (2015). Pancréatites d’origine médicamenteuse. Revue des notifications spontanées en France. La Revue de Médecine Interne. 36(9). 573–578. 12 indexed citations
20.
Chebane, Leila, et al.. (2010). Hyperglycémies d’origine médicamenteuse : étude dans la Base Nationale Française de PharmacoVigilance (BNPV). Therapies. 65(5). 447–458. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justine Bénevent Breakdown of academic impact, for papers by Yamato Kato Breakdown of academic impact, for papers by Francesco Giorgianni Breakdown of academic impact, for papers by Michele Tari Breakdown of academic impact, for papers by Giuseppe Cicala Breakdown of academic impact, for papers by Supriya Malhotra Breakdown of academic impact, for papers by Sigal Kaplan Breakdown of academic impact, for papers by Boyang Bian Breakdown of academic impact, for papers by Tracey L. Mersfelder Breakdown of academic impact, for papers by Bharti Chogtu
Rankless by CCL
2026